It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Tissue-resident memory T (TRM) cells are characterized by their surface expression of CD69 and can be subdivided in CD103+ and CD103− TRM cells. The origin and functional characteristics of TRM cells in the renal allograft are largely unknown. To determine these features we studied TRM cells in transplant nephrectomies. TRM cells with a CD103+ and CD103− phenotype were present in all samples (n = 13) and were mainly CD8+ T cells. Of note, donor-derived TRM cells were only detectable in renal allografts that failed in the first month after transplantation. Grafts, which failed later, mainly contained recipient derived TRM cells. The gene expression profiles of the recipient derived CD8+ TRM cells were studied in more detail and showed a previously described signature of tissue residence within both CD103+ and CD103− TRM cells. All CD8+ TRM cells had strong effector abilities through the production of IFNγ and TNFα, and harboured high levels of intracellular granzyme B and low levels of perforin. In conclusion, our results demonstrate that donor and recipient TRM cells reside in the rejected renal allograft. Over time, the donor-derived TRM cells are replaced by recipient TRM cells which have features that enables these cells to aggressively respond to the allograft.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Department of Internal Medicine, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X); Division of HPB & Transplant Surgery, Erasmus MC, University Medical Center Rotterdam, Department of Surgery, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
2 Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Department of Internal Medicine, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
3 Erasmus MC, University Medical Center Rotterdam, Department of Pulmonary Medicine, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
4 Division of HPB & Transplant Surgery, Erasmus MC, University Medical Center Rotterdam, Department of Surgery, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
5 Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
6 Erasmus MC, University Medical Center Rotterdam, Department of Pathology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)